Promotes autolytic debridement

"Promotes autolytic debridement" is not a molecule, receptor, or canonical therapeutic target. Instead, it describes a *process* by which the body’s own enzymes and natural fluids break down and remove devitalized (necrotic) tissue from a wound. This process is facilitated by maintaining a moist wound environment using specific dressings such as hydrogels, hydrocolloids, alginates, foams, or transparent films[1][4][7]. Autolytic debridement is highly selective—only necrotic tissue is liquefied—and generally painless but slow to act. It plays an important role in wound bed preparation for chronic wounds but should not be used when there are large amounts of dead tissue or active infection present due to risk of delayed healing and complications like maceration of healthy skin[1][2][6]. There are no drugs that directly target this process; rather, various dressings are used to create the optimal conditions for autolysis. **Summary:** The entry “Promotes autolytic debridement” does not refer to any specific molecular entity or drug target but rather describes an effect/process relevant in clinical wound care management.

Other names

Autolytic debridementPromotes autolytic debridement